Hisamitsu Pharmaceutical Co (FRA:HPX) Inventories, Raw Materials & Components: €56.6 Mil (As of Nov. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HPX Hisamitsu Pharmaceutical Co Inc FRA:HPX
65 GF Score
Price €31.80
GF Value €25.90
View Full Analysis

What is Hisamitsu Pharmaceutical Co Inventories, Raw Materials & Components?

Hisamitsu Pharmaceutical Co FRA:HPX 65 Inventories, Raw Materials & Components is €56.6 Mil as of Nov. 2025. GuruFocus rates FRA:HPX with a GF Score™ of 65/100 and a GF Value™ of €25.90.

Hisamitsu Pharmaceutical Co's inventories, raw materials & components for the quarter that ended in Nov. 2025 was €56.6 Mil.

Hisamitsu Pharmaceutical Co's quarterly raw materials declined from May. 2025 (€61.5 Mil) to Aug. 2025 (€61.3 Mil) and declined from Aug. 2025 (€61.3 Mil) to Nov. 2025 (€56.6 Mil).

Hisamitsu Pharmaceutical Co's annual raw materials increased from Feb. 2024 (€54.7 Mil) to Feb. 2025 (€60.5 Mil) but then declined from Feb. 2025 (€60.5 Mil) to Feb. 2026 (€59.5 Mil).

Hisamitsu Pharmaceutical Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Hisamitsu Pharmaceutical Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co Inventories, Raw Materials & Components Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.92 56.37 54.73 60.51 59.48

Hisamitsu Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.51 61.51 61.34 56.65 59.48
FRA:HPX
65GF Score
Hisamitsu Pharmaceutical Co Inc FRA:HPX
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hisamitsu Pharmaceutical Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €56.6 Mil mean?
Hisamitsu Pharmaceutical Co (FRA:HPX) has a Inventories, Raw Materials & Components of €56.6 Mil as of Nov. 2025. Raw materials are the components a company uses for its main products. View historical data on Hisamitsu Pharmaceutical Co and its competitors.
Is Hisamitsu Pharmaceutical Co's Inventories, Raw Materials & Components too high?
Hisamitsu Pharmaceutical Co's current Inventories, Raw Materials & Components is €56.6 Mil. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's Inventories, Raw Materials & Components compare to ESPR and AMPH?
Hisamitsu Pharmaceutical Co's Inventories, Raw Materials & Components of €56.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Hisamitsu Pharmaceutical Co and its competitors. Hisamitsu Pharmaceutical Co's current Inventories, Raw Materials & Components is €56.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Hisamitsu Pharmaceutical Co (FRA:HPX) has a current Inventories, Raw Materials & Components of €56.6 Mil. The stock's GF Value™ is €25.90, compared to a current price of €31.80 — trading 22.8% above its estimated fair value. The current Inventories, Raw Materials & Components is €56.6 Mil. Hisamitsu Pharmaceutical Co's overall GF Score™ is 65/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (FRA:HPX), the current Inventories, Raw Materials & Components is €56.6 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hisamitsu Pharmaceutical Co (FRA:HPX) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of €31.80 is trading 22.8% above its estimated GF Value™ of €25.90.

Key valuation signals for FRA:HPX:

  • Inventories, Raw Materials & Components: €56.6 Mil
  • GF Value™: €25.90 vs. price of €31.80 (22.8% above fair value)
  • GF Score™: 65/100

No single metric tells the full story. See the FRA:HPX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hisamitsu Pharmaceutical Co Business Description

Other Exchanges HTSUY:USA
Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
65GF Score

Get the complete analysis for FRA:HPX

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€31.80
Price
€25.90
GF Value